HBV, HCV, and HDV Triple-Infection—A Therapeutic Challenge
Compared to patients with a single hepatotropic viral infection, those with a double or triple infection had more severe hepatic damage. Concomitant therapy with Bulevirtide, DAAs, and NUCs is possible and the therapeutic results from clinical studies, with single-infection patients showing great potential for improving the prognosis of these patients.
Authors
- Liliana Baroiu (ORCID: https://orcid.org/0000-0002-7602-8435)
- Mihaela Debita (ORCID: https://orcid.org/0000-0001-8523-6319)
- Caterina Dumitru (ORCID: https://orcid.org/0000-0001-8953-6538)
- Lavinia-Alexandra Moroianu (ORCID: https://orcid.org/0000-0001-9688-0580)
- Alexia Anastasia Ștefania Balta
- Valerii Luțenco (ORCID: https://orcid.org/0009-0001-6620-7851)
- Valentin Bulza
- Mariana Daniela Ignat
- Raisa Eloise Barbu (ORCID: https://orcid.org/0009-0008-3466-4717)
- Mihaela Patriciu
Institutions
- Clinical Emergency Hospital Bucharest (RO)
- "Dunarea de Jos" University of Galati (RO)
- Spitalul Clinic de Urgenta Sfantul Ioan (RO)
Publication Details
- Journal
- Diseases
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3390/diseases13060168
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Universitatea 'Dunărea de Jos' Galați